ATE123222T1 - Behandlung der rnase l-defizienz mit ds rns. - Google Patents

Behandlung der rnase l-defizienz mit ds rns.

Info

Publication number
ATE123222T1
ATE123222T1 AT88306419T AT88306419T ATE123222T1 AT E123222 T1 ATE123222 T1 AT E123222T1 AT 88306419 T AT88306419 T AT 88306419T AT 88306419 T AT88306419 T AT 88306419T AT E123222 T1 ATE123222 T1 AT E123222T1
Authority
AT
Austria
Prior art keywords
rnase
mononuclear cells
rns
deficiency
ability
Prior art date
Application number
AT88306419T
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Pharma Corp filed Critical Hem Pharma Corp
Application granted granted Critical
Publication of ATE123222T1 publication Critical patent/ATE123222T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
AT88306419T 1987-07-17 1988-07-13 Behandlung der rnase l-defizienz mit ds rns. ATE123222T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7464987A 1987-07-17 1987-07-17

Publications (1)

Publication Number Publication Date
ATE123222T1 true ATE123222T1 (de) 1995-06-15

Family

ID=22120800

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88306419T ATE123222T1 (de) 1987-07-17 1988-07-13 Behandlung der rnase l-defizienz mit ds rns.

Country Status (18)

Country Link
EP (2) EP0525917A3 (de)
JP (1) JPH01104015A (de)
KR (1) KR970007903B1 (de)
CN (1) CN1032741A (de)
AT (1) ATE123222T1 (de)
AU (3) AU1820388A (de)
CA (1) CA1331345C (de)
DE (1) DE3853898T2 (de)
DK (1) DK363088A (de)
ES (1) ES2075835T3 (de)
FI (1) FI883351A (de)
GR (1) GR3017271T3 (de)
IE (1) IE75896B1 (de)
IL (1) IL86865A (de)
NO (1) NO882854L (de)
PT (1) PT87997B (de)
RU (1) RU1838419C (de)
ZA (1) ZA885095B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
DE3853755T2 (de) * 1987-09-04 1995-12-14 Hem Pharma Corp Diagnose von Mangelzuständen doppelsträngiger RNS.
NO883868L (no) * 1987-09-04 1989-03-06 Hem Res Inc Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
ATE103493T1 (de) * 1988-07-07 1994-04-15 Hem Pharma Corp Diagnose und behandlung chronischer ermuedungserscheinungen.
HUT65404A (en) * 1989-10-11 1994-06-28 Hem Res Inc Protection from shock subsequent to injury by double-stranded rnas
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
AU2268892A (en) * 1991-07-16 1993-02-23 Hem Pharmaceuticals Corp. Modulation and diagnosis of cytokine dysfunctions
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
TW524693B (en) * 1997-10-16 2003-03-21 Nippon Shinyaku Co Ltd Cancer cell nuclease activator
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
CN100358534C (zh) * 2005-11-21 2008-01-02 北京百林康源生物技术有限责任公司 错位双链寡核苷酸在制备治疗禽流感病毒感染的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
DK363088D0 (da) 1988-06-30
FI883351A0 (fi) 1988-07-14
EP0299745A2 (de) 1989-01-18
IL86865A0 (en) 1988-11-30
EP0299745B1 (de) 1995-05-31
RU1838419C (ru) 1993-08-30
DK363088A (da) 1989-01-18
KR890002420A (ko) 1989-04-10
EP0525917A3 (de) 1993-02-24
AU1502695A (en) 1995-07-06
ZA885095B (en) 1989-07-26
FI883351A (fi) 1989-01-18
IE75896B1 (en) 1997-09-24
ES2075835T3 (es) 1995-10-16
GR3017271T3 (en) 1995-11-30
CA1331345C (en) 1994-08-09
CN1032741A (zh) 1989-05-10
IE881895L (en) 1989-01-17
PT87997B (pt) 1995-03-01
JPH01104015A (ja) 1989-04-21
PT87997A (pt) 1989-06-30
DE3853898D1 (de) 1995-07-06
IL86865A (en) 1993-06-10
AU1619092A (en) 1992-08-13
NO882854D0 (no) 1988-06-28
EP0299745A3 (en) 1989-12-06
NO882854L (no) 1989-01-18
DE3853898T2 (de) 1996-02-29
KR970007903B1 (ko) 1997-05-17
EP0525917A2 (de) 1993-02-03
AU1820388A (en) 1989-01-19

Similar Documents

Publication Publication Date Title
ATE123222T1 (de) Behandlung der rnase l-defizienz mit ds rns.
UA6035A1 (uk) Засіб для визначення лейкоцітів в сечі
DE3782917D1 (de) Verfahren zum herabsetzen des gehalts an rueckstaendigen aldehyden in implantierbaren bioprosthetischen geweben.
IT8026821A0 (it) Cementi solubili in acidi e metodi per impiegarli.
ATE543T1 (de) Diagnostisches mittel, verfahren zu dessen herstellung sowie dessen verwendung zum nachweis von leukozyten in koerperfluessigkeiten.
ES8800029A1 (es) Aparato para supervisar los cambios de actividad de reduccion-oxidacion in vivo.
ATE120497T1 (de) Verfahren zur voraussage der wirksamkeit einer antineoplastichen behandlung bei einzelnen patienten.
DE2960857D1 (en) Diagnostic means for the detection of proteolytic enzymes and indoxyl or thioindoxyl ester chromogens useful therefor, process for their preparation and their use in the preparation of diagnostic means
ATE360989T1 (de) Präzise wirksamkeitsbestimmungsmethode für wirkstoffe einschliesslich chemotherapeutika
MA19147A1 (fr) Derives de pyridoxine,leur procede de preparation ainsi que leur utilisation en therapeutique .
DE3863379D1 (de) Verfahren zur lokalen erhoehung des brechungsindizes eines elektrooptischen, in gefuehrter wellenleiteroptik zu verwendenden materials und nach diesem verfahren hergestelltes material.
IT8448540A0 (it) Proteine umane, antisieri per esse, procedimento per prepararli e corredi di prova che li contengono
IT7822245A0 (it) Procedimento per la produzione di particelle di colorante idrosolubili, resistenti all'usura, che non impolverano e che sono solubili in acqua.
JPS5696239A (en) Continuous monitor method of all concentration of series of ionntypes in flow
DE3585049D1 (de) Monoklonale antikoerper.
BE863089A (fr) Inhibiteur d'alpha-amylase, son procede de preparation a partir d'un streptomycete et son application en therapeutique
ES8106966A1 (es) Procedimiento para la deteccion de sustancias con efecto pe-roxidante
IE890612L (en) Inhibitors of lysyl oxidase
HUT47747A (en) Method for correction defective ways of metabolism related to cycles of growth of spontaneous tomour-cells and viruses, with double-stranded rns
JPS56150356A (en) Immunologic measuring method
JPS51144293A (en) Continuous analysis system of urine, etc
HU177782B (en) Method for detecting need in water of the and in this context for metering ph-value of the soil,as well as,apparatus for the latter purpose
ATE22325T1 (de) Verfahren und gaserzeugereinheit zur verwendung in mikrobiologischer zucht.
IT8620806A0 (it) Composizione terapeutica inibitrice del fumo e degli oppiacei e metodo per la sua preparazione.
ATE10112T1 (de) Verfahren zur fluorimetrischen bestimmung der aktivitaet von fettspaltenden enzymen und mittel zur durchfuehrung dieses verfahrens.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee